RRP is a rare degenerative disease that causes small growths (papillomas) in the respiratory tract. Generally, non-cancerous papillomas can cause severe and life-threatening airway obstruction and respiratory complications. Inovio believes that the Innovation Passport designation grant further bolsters the potential of INO-3107 to "transform" the treatment paradigm for RRP patients. The company, however, plans to initiate a confirmatory study of INO-3107 for RRP before submitting the BLA to the FDA. Apart f ...